Skip to content
Open access

Association between pre-admission cardiovascular pharmacotherapy and initial stroke severity in a single-centre cohort

Oct 2026 · ANPAbstract_CBN26 · 0 citations

Abstract

Background: Stroke remains a leading cause of mortality and long-term disability worldwide. Although chronic cardiovascular pharmacotherapy, including antihypertensive, antiplatelet, anticoagulant, and antidiabetic agents, is widely used to reduce cerebrovascular risk, its potential influence on the initial clinical severity of stroke remains uncertain. Objective: This study aimed to investigate the association between pre-admission cardiovascular medication use and stroke severity at hospital presentation. Methods: This observational study included consecutive patients with a confirmed diagnosis of acute cerebrovascular accident treated at a single tertiary center. Stroke severity at admission was assessed using the National Institutes of Health Stroke Scale (NIHSS). Pre-admission exposure to antihypertensive, antiplatelet, anticoagulant, and antidiabetic medications was recorded from medical records. The primary objective was to evaluate differences in admission NIHSS according to prior medication use. The Shapiro–Wilk test was used to assess distribution of continuous variables. Comparisons between medication exposure groups and NIHSS were performed using the Mann–Whitney U test. The association between age and stroke severity was evaluated using Spearman’s rank correlation coefficient. A multivariable negative binomial regression model with log link function was constructed to assess independent associations between prior medication exposure and NIHSS at admission. Results: A total of 104 patients were included and the mean NIHSS at admission was 7.64. In univariate analyses, prior anticoagulant use was significantly associated with NIHSS at admission (p=0.015). No statistically significant differences in stroke severity were observed among patients using antidiabetic agents (p=0.519), antihypertensive therapy (p=0.970), or antiplatelet agents (p=0.927). Age demonstrated a weak but statistically significant positive correlation with NIHSS (Spearman’s rho=0.233; p=0.017). In the multivariable negative binomial regression model, the overall model was not statistically significant (p=0.384). After adjustment, no independent association was observed between NIHSS and age (p=0.19), anticoagulant use (p=0.55), antiplatelet use (p=0.49), antihypertensive therapy (p=0.48), or antidiabetic therapy (p=0.78). Conclusion: In this single-centre cohort, pre-admission cardiovascular pharmacotherapy was not independently associated with initial stroke severity as measured by the NIHSS. Although a univariate association was observed for anticoagulant use, this finding was not maintained after multivariable adjustment. These results suggest that factors such as stroke subtype, lesion location, time to presentation, and comorbidity burden may exert a greater influence on early neurological deficit. Larger multicentre studies are needed to further clarify these associations.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.